Cimzia® (certolizumab peg) is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker. Cimzia is used in adult patients to:
- Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in patients who have not been helped enough by usual treatments.
- Treat moderately to severely active rheumatoid arthritis (RA).
- Treat active psoriatic arthritis (PsA).
- Treat active ankylosing spondylitis (AS)
For more information, visit www.cimzia.com.